Frédéric Jung

1.5k total citations
29 papers, 853 citations indexed

About

Frédéric Jung is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Frédéric Jung has authored 29 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Organic Chemistry, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Frédéric Jung's work include Microtubule and mitosis dynamics (6 papers), Cancer-related Molecular Pathways (6 papers) and Chemical Synthesis and Analysis (4 papers). Frédéric Jung is often cited by papers focused on Microtubule and mitosis dynamics (6 papers), Cancer-related Molecular Pathways (6 papers) and Chemical Synthesis and Analysis (4 papers). Frédéric Jung collaborates with scholars based in France, United Kingdom and United States. Frédéric Jung's co-authors include Andrew Mortlock, Nicola M. Heron, Stephen Green, Robert W. Wilkinson, Kevin M. Foote, Nicholas Keen, Tony Durst, Rajesh Odedra, Stephen R. Wedge and Madeleine C. Brady and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Clinical Cancer Research.

In The Last Decade

Frédéric Jung

28 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frédéric Jung France	15	408	341	327	315	46	29	853
Kate F. Byth United States	15	520 1.3×	281 0.8×	228 0.7×	400 1.3×	45 1.0×	20	1.0k
Melvin J. Yu United States	17	402 1.0×	116 0.3×	326 1.0×	422 1.3×	16 0.3×	30	1.1k
Keith W. Woods United States	19	613 1.5×	109 0.3×	789 2.4×	164 0.5×	21 0.5×	30	1.3k
Matthew M. Hayward United States	15	909 2.2×	96 0.3×	612 1.9×	235 0.7×	99 2.2×	24	1.4k
Jessica J. Field New Zealand	12	569 1.4×	371 1.1×	440 1.3×	314 1.0×	7 0.2×	23	1.1k
Alfonso de Dios Spain	18	494 1.2×	121 0.4×	440 1.3×	1.0k 3.2×	22 0.5×	38	1.8k
Gui‐Dong Zhu United States	20	695 1.7×	78 0.2×	490 1.5×	563 1.8×	18 0.4×	42	1.4k
Ben Cornett United States	8	473 1.2×	408 1.2×	214 0.7×	496 1.6×	4 0.1×	10	841
Keizo Koya United States	19	627 1.5×	77 0.2×	406 1.2×	205 0.7×	16 0.3×	31	1.2k
Maria Gabriella Brasca Italy	17	345 0.8×	91 0.3×	276 0.8×	186 0.6×	10 0.2×	28	663

Countries citing papers authored by Frédéric Jung

Since Specialization

Citations

This map shows the geographic impact of Frédéric Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Jung more than expected).

Fields of papers citing papers by Frédéric Jung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Jung. The network helps show where Frédéric Jung may publish in the future.

Co-authorship network of co-authors of Frédéric Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Jung. A scholar is included among the top collaborators of Frédéric Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Jung. Frédéric Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Plé, Patrick A., Frédéric Jung, Sue Ashton, et al.. (2012). Discovery of new quinoline ether inhibitors with high affinity and selectivity for PDGFR tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 22(9). 3050–3055. 7 indexed citations

Plé, Patrick A., Frédéric Jung, Sue Ashton, et al.. (2012). ChemInform Abstract: Discovery of AZD2932 (I), a New Quinazoline Ether Inhibitor with High Affinity for VEGFR‐2 and PDGFR Tyrosine Kinases.. ChemInform. 43(20). 1 indexed citations

Ducray, Richard, Iain Simpson, Frédéric Jung, et al.. (2011). Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 21(16). 4698–4701. 44 indexed citations

Ducray, Richard, Clifford D. Jones, Frédéric Jung, et al.. (2011). Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: Optimization of the aniline. Bioorganic & Medicinal Chemistry Letters. 21(16). 4702–4704. 36 indexed citations

Plé, Patrick A., Frédéric Jung, Sue Ashton, et al.. (2011). Discovery of AZD2932, a new Quinazoline Ether Inhibitor with high affinity for VEGFR-2 and PDGFR tyrosine kinases. Bioorganic & Medicinal Chemistry Letters. 22(1). 262–266. 44 indexed citations

Foote, Kevin M., Andrew Mortlock, Nicola M. Heron, et al.. (2008). Synthesis and SAR of 1-acetanilide-4-aminopyrazole-substituted quinazolines: Selective inhibitors of Aurora B kinase with potent anti-tumor activity. Bioorganic & Medicinal Chemistry Letters. 18(6). 1904–1909. 32 indexed citations

Wilkinson, Robert W., Rajesh Odedra, Simon P. Heaton, et al.. (2007). AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis. Clinical Cancer Research. 13(12). 3682–3688. 278 indexed citations

Wilkinson, Robert W., Nicholas Keen, Rajesh Odedra, et al.. (2006). AZD1152: A highly potent and specific aurora kinase inhibitor.. Cancer Research. 66. 1333–1334. 6 indexed citations

Heron, Nicola M., Malcolm Anderson, David P. Blowers, et al.. (2005). SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(5). 1320–1323. 101 indexed citations

10.

Mortlock, Andrew, Nicholas Keen, Frédéric Jung, et al.. (2005). Progress in the Development of Selective Inhibitors of Aurora Kinases. Current Topics in Medicinal Chemistry. 5(2). 199–213. 19 indexed citations

11.

12.

Morris, William P., et al.. (1999). A novel series of non-nucleoside inhibitors of inosine 5′-monophosphate dehydrogenase with immunosuppressive activity§§Abbreviations: β, coefficient of interaction; DTH, delayed-type hypersensitivity; FBS, foetal bovine serum; IMP, inosine 5′-monophosphate; IMPDH, IMP dehydrogenase; K′i, apparent inhibition constant for compound I; Kii, inhibition constant for effect on intercept of Lineweaver–Burk plots; K′x, apparent inhibition constant for compound X; MFT, mycophenolate mofetil; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; MPA, mycophenolic acid; TCA, trichloroacteic acid (10% w/v); v, velocity; v0, uninhibited velocity; and XMP, xanthosine monophosphate.. Biochemical Pharmacology. 58(5). 867–876. 10 indexed citations

13.

Genêt, Jean‐Pierre, Jean‐Olivier Durand, Sylvain Roland, Monique Savignac, & Frédéric Jung. (1997). Synthesis of 3-fluoro azetidinone by electrophilic fluorination. Tetrahedron Letters. 38(1). 69–72. 19 indexed citations

14.

Roland, Sylvain, et al.. (1995). π-Allyl palladium ring closure strategy for the synthesis of a 1β-methylcarbapenem intermediate. Tetrahedron Letters. 36(17). 3007–3010. 14 indexed citations

15.

Jung, Frédéric, et al.. (1993). Synthesis and structure-activity relationships of new cephalosporins with aminoimidazoles at C-7. Effect of the pKa of the C-7 aminoimidazole on antibacterial spectrum and .BETA.-lactamase stability.. The Journal of Antibiotics. 46(6). 992–1012. 12 indexed citations

16.

Jung, Frédéric, et al.. (1991). Synthesis and structure-activity relationship of new cephalosporins with amino heterocycles at C-7. Dependence of the antibacterial spectrum and .beta.-lactamase stability on the pKa of the C-7 heterocycle. Journal of Medicinal Chemistry. 34(3). 1110–1116. 16 indexed citations

17.

Jung, Frédéric, et al.. (1989). A new approach to the synthesis of amino imidazoles application to the cephalosporin series. Tetrahedron Letters. 30(18). 2379–2382. 8 indexed citations

18.

Jung, Frédéric, et al.. (1974). ChemInform Abstract: DECOMPOSITION OF 3,6‐DIHYDRO‐1,2‐OXATHIIN 2‐OXIDES TO SULFUR DIOXIDE AND 1,3‐DIENES. A(PI)4(S)+(PI)2(S) CYCLOREVERSION. Chemischer Informationsdienst. 5(16). 2 indexed citations

19.

Jung, Frédéric, et al.. (1973). ChemInform Abstract: BETA-SULTINES, INTERMEDIATES IN A SULFUR ANALOG OF THE WITTIG OLEFIN SYNTHESIS. Chemischer Informationsdienst. 4(30). no–no. 5 indexed citations

20.

Oehme, P, et al.. (1972). [Pharmacology of hydrazino carbonic acids, hydrazino peptides and other hydrazine derivatives. Structure-action studies in heterologeous eledoisin octapeptide sequences].. PubMed. 28(1). 109–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact